Supported by an independent educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals.
Atopic dermatitis, often incorrectly referred to as eczema, is an inflammatory skin disorder most commonly presenting during early childhood and affecting individuals through adulthood. Disease burden on the health care system is estimated to exceed $4.3 billion annually with urgent care costs doubling in recent years. The recurrent nature of intense itching and eczematous lesions along with increased risk for other diseases of atopy can lead to a significant burden on quality of life. Advances in identifying the genetic and immunologic components of atopic dermatitis is fueling an expansive growth of novel treatment approaches. This will result in improved disease burden with increased utilization and costs.
During this session, faculty will discuss the complications atopic dermatitis has on quality of life at various ages, treatment strategies to minimize disease burden, the health care utilization and costs involved with the management of atopic dermatitis, and explore emerging agents that improve outcomes in different age groups with atopic dermatitis.
At the completion of this knowledge-based activity, participants will be able to:
- Define the etiology and clinical presentation of atopic dermatitis.
- Describe the influence atopic dermatitis has on quality of life both mentally and physically for children, adolescents, adults, and their caregivers.
- Recognize the impact atopic dermatitis has on health care utilization and prescription drug costs within managed care organizations.
- Discuss current and pipeline treatment options for different age groups with atopic dermatitis.
Clive Liu, MD, PLLC, FABD
Director of the Psoriasis Treatment Center
Stephanie Cho, PharmD, BCPS
Clinical Pharmacy Specialist in Dermatology
Kaiser Permanente Colorado
Ashley Ellis, PharmD, CDECS
ImPAcT Director & Assistant Professor
The University of Tennessee Health Science Center
Department of Clinical Pharmacy and Translation Science
College of Pharmacy
Cynthia Reilly, MS, BS Pharm
Chief Operating Officer
The Academy of Managed Care Pharmacy (AMCP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
ACPE UAN:0233-0000-21-056-H01-P • Activity Type: Knowledge-Based
Contact Hours: 1.5
Release Date: October 19, 2021 • Expiration Date: December 31, 2022
Activity Fee: Free for Members and Non-Members
Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live activity that was held in conjunction with Nexus 2021. CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.
To receive credit for an online activity you must:
- Review the full content of the activity.
- Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
- Complete a specific activity evaluation.
System Technical Requirements/Viewing Requirements:
System Requirements Courses and learning activities are delivered via your Web browser and Acrobat PDF. For all activities, you should have a basic comfort level using a computer and navigating websites. View the minimum technical and system requirements for continuing education online learning activities.
|Activity Number||Credit Amount||Accreditation Period|
|ACPE UAN #0233-0000-21-056-H01-P||1.5 Contact Hours||October 19, 2021 - December 31, 2022|